Ozzy Osbourne says he “can’t walk” due to Parkinson’s disease ahead of Black Sabbath reunion show
Singer and songwriter Ozzy Osbourne, who rose to fame during the 1970s as the lead singer of the band Black Sabbath, is excited about his upcoming farewell concert with his Black Sabbath bandmates, but he shared he won’t be able to walk because of his Parkinson’s disease.
Red flags of Parkinson's disease
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback